tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CERE

Cerevel Therapeutics’ Corporate Transformation and Market Delisting
Company AnnouncementsCerevel Therapeutics’ Corporate Transformation and Market Delisting
5M ago
8K
CERE
AbbVie completes acquisition of Cerevel Therapeutics
PremiumThe Fly
AbbVie completes acquisition of Cerevel Therapeutics
5M ago
ABBV
CERE
CERE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CERE Upcoming Earnings Report: What to Expect?
5M ago
CERE
AbbVie expects Cerevel Therapeutics transaction to close ‘soon’
PremiumThe Fly
AbbVie expects Cerevel Therapeutics transaction to close ‘soon’
5M ago
ABBV
CERE
Cerevel Therapeutics weakness attributed to CTFN report
PremiumThe Fly
Cerevel Therapeutics weakness attributed to CTFN report
6M ago
ABBV
CERE
Soros buys Okta, cuts Amazon in Q1
PremiumThe FlySoros buys Okta, cuts Amazon in Q1
7M ago
AER
CRH
CERE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CERE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
CERE
Cerevel Therapeutics’ tavapadon meets Phase 3 primary endpoint in Parkinson’s
Premium
The Fly
Cerevel Therapeutics’ tavapadon meets Phase 3 primary endpoint in Parkinson’s
8M ago
CERE
CERE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CERE Upcoming Earnings Report: What to Expect?
9M ago
CERE
Cerevel Therapeutics Advances in Merger Amid FTC Review
PremiumCompany Announcements
Cerevel Therapeutics Advances in Merger Amid FTC Review
10M ago
8K
CERE
Cerevel Therapeutics price target raised to $45 from $25 at Mizuho
PremiumThe Fly
Cerevel Therapeutics price target raised to $45 from $25 at Mizuho
10M ago
CERE
Neurocrine price target raised to $106 from $100 at Piper Sandler
PremiumThe Fly
Neurocrine price target raised to $106 from $100 at Piper Sandler
11M ago
CERE
KRTX
Neumora Therapeutics appoints Panandiker as Chief Commercial Officer
PremiumThe FlyNeumora Therapeutics appoints Panandiker as Chief Commercial Officer
11M ago
CERE
NMRA
Cerevel Therapeutics price target raised to $45 from $25 at JPMorgan
Premium
The Fly
Cerevel Therapeutics price target raised to $45 from $25 at JPMorgan
12M ago
ABBV
CERE
Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
Premium
The Fly
Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
12M ago
ARM
BMY
Reviva may be most undervalued in neurology, says H.C. Wainwright
PremiumThe Fly
Reviva may be most undervalued in neurology, says H.C. Wainwright
12M ago
CERE
KRTX
Cerevel Therapeutics price target raised to $45 from $30 at Wells Fargo
PremiumThe Fly
Cerevel Therapeutics price target raised to $45 from $30 at Wells Fargo
12M ago
ABBV
CERE
Cerevel Therapeutics downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Cerevel Therapeutics downgraded to Hold from Buy at Jefferies
1y ago
CERE
Cerevel Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe Fly
Cerevel Therapeutics downgraded to Hold from Buy at Stifel
1y ago
CERE
Cerevel Therapeutics just downgraded at Stifel, here’s why
PremiumThe FlyCerevel Therapeutics just downgraded at Stifel, here’s why
1y ago
CERE
The biopharma stocks to own in 2024, according to Morgan Stanley
Premium
The Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
1y ago
BMY
JNJ
The biopharma stocks to own in 2024, according to Morgan Stanley
Premium
The Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
1y ago
BMY
JNJ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >